(5-Arylfuran-2-ylcarbonyl)guanidines as Cardioprotectives through the Inhibition of Na+/H+ Exchanger Isoform-1-Reference-Cited by-同舟云学术

(5-Arylfuran-2-ylcarbonyl)guanidines as Cardioprotectives through the Inhibition of Na+/H+ Exchanger Isoform-1

Published:2005-03-30 Issue:8 Volume:48 Page:2882-2891
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lee Sunkyung¹,Yi Kyu Yang¹,Hwang Sun Kyung¹,Lee Byung Ho¹,Yoo Sung-eun¹,Lee Kyunghee¹

Affiliation:

1. Medicinal Science Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon 305-600, Korea, and Central Research Center of Yuyu Inc., Kyounggi-do 430-804, Korea

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0492305

Reference30 articles.

1. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion

2. Cardiac protection during acute myocardial infarction: Where do we stand in 2004?

3. Na+/h+exchange inhibitors for cardioprotective therapy: progress, problems and prospects

4. Rational basis for use of sodium–hydrogen exchange inhibitors in myocardial ischemia

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sulfur-Promoted Oxidative Cyclization of Pentan-1-ones: Direct Access to Tetrasubstituted Furans from Deoxybenzoins and Chalcones;Organic Letters;2023-08-22

2. Atom‐economic Approach to the Synthesis of α‐(Hetero)aryl‐substituted Furan Derivatives from Biomass;Chemistry – An Asian Journal;2021-12-09

3. Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors;Scientific Reports;2021-12

4. Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation;European Journal of Medicinal Chemistry;2020-11

5. 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer;Journal of Medicinal Chemistry;2018-08-21